Additionally, the TNF and p53 signaling pathways were common, with regulatory involvement from genes such as RHGAP1, SLC10A1, and SIX5. P53 appears to contribute to liver steatosis in MASH patients by inducing the miR-34a-HNF4α pathway. Here, SLC10A1 is linked to metabolic dysfunction-associated steatohepatitis.